A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

This study is currently recruiting participants.

Study NCT01326871 Information provided by Altor Bioscience Corporation

First Received: March 30, 2011 Last Updated: February 27, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2014
Estimated Primary Completion Date:	March 2014 (Final data collection date for primary outcome measure)